Net income of Fulgent Genetics under GAAP for 2021 was $506.239 million, up 2.4 times from $214.31 million in the previous year. Revenue increased 2.4 times to $992.584 million from $421.712 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept